# Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

> **NCT03075969** · — · UNKNOWN · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 337 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03075969
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-03
- **Primary completion:** 2019-03-16
- **Final completion:** 2019-12
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03075969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03075969, "Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03075969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*